CN Stock MarketDetailed Quotes

688428 InnoCare Pharma

Watchlist
  • 11.66
  • -0.04-0.34%
Market Closed Sep 13 15:00 CST
20.55BMarket Cap-43670P/E (TTM)

InnoCare Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

InnoCare Pharma H1 FY2024 Earnings Date

Currency：CNYAug 20, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
362.10M
419.74M
+57.64M
Beat Est.
--
+11.17%
+29.37%
EPS
-0.21
-0.16
+0.05
Beat Est.
+16.01%
+35.01%
--
Analyst Rating
Strong Buy

Sep 13, 2024

InnoCare Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 272.790M--
--2024/Q3-- / 216.000M--
--2024/Q2251.176M / 196.275M--
May 14, 20242024/Q1165.824M / 181.644M--
--2023/Q4201.175M / 176.345M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 272.790M--
--2024/Q3-- / 216.000M--
--2024/Q2251.176M / 196.275M--
May 14, 20242024/Q1165.824M / 181.644M--
--2023/Q4201.175M / 176.345M--

Unlock Free Earnings Estimates

InnoCare Pharma Earnings Reports

  • InnoCare Pharma: Announcement of midterm performance for the six months ending on June 30, 2024.

    Aug 20 12:00 ET

  • Innocare Pharmaceutical Co., Ltd. Summary of 2024 Interim Report

    Aug 20 12:00 ET

  • Innocare Pharmaceuticals Co., Ltd. 2024 Half-year Report

    Aug 20 12:00 ET

  • Nuochengjianhua Pharmaceutical Co., Ltd. report for the first quarter of 2024

    May 13 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 13, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data